This study is helpful for expanding our understanding of pre-mRNA alternative splicing regulation by snoRNA and protein partners, and suggests that targeting SNORA37/CMTR1/ELAVL1 feedback loop is a potential therapeutic strategy for human cancers, while its potential role in tumor microenvironment warrants further investigation. The gene discussed is ELAVL1; the disease is cancer.